First, as a single-case report, the insights generated are descriptive and hypothesis-generating; the favorable treatment response observed may not be generalizable to all SMARCA4-DNSCLC and could be influenced by the unique biology of this tumor or the multi-modal therapy itself. The gene discussed is SMARCA4; the disease is neoplasm.